Literature DB >> 21886725

Cutaneous cholesterol embolization.

Gulden Avci1, Tayfun Akoz, Aylin Ege Gul.   

Abstract

BACKGROUND: Cutaneous cholesterol embolization syndrome occurs as a result of cholesterol embolization from atherosclerotic plaques lining the walls of arteries and arterioles. It can occur sporadically but is more commonly associated with iatrogenic manipulation via invasive vascular procedures or therapies (anticoagulation or thrombolytics) The three most common organ systems afflicted by cholesterol emboli include the kidneys, gastrointestinal system, and skin. MAIN OBSERVATIONS: We present two patients with cutaneous cholesterol embolization A 74-year-old with no prior disease or trauma was referred to the hospital with the acute chest pain. After 24-48 he developed livedo reticularis, followed by necrotic areas like bilaterally on hips and in the lumbar region. The second patient, 69-year-old man with a history of hyperglycemia, hyperlipidaemia, and hypertension was referred with weight loss, bilateral livedo reticularis, severe pain of lower extremities and impaired renal function. The toes first became cyanotic and than skin necrosis developed. Skin biopsy revealed presence of cholesterol clefts in the lumina of small arteries and arterioles. In both patients the necrotic skin and subcutaneous tissue had been debrided. Daily dressing was applied and tissue defects underwent secondary healing.
CONCLUSION: The diagnosis of cholesterol embolization relies on clinical and histologic examination. Both, diagnosis and treatment needs a multidisciplinary approach, especially in cases of multi-organ involvement.

Entities:  

Keywords:  cholesterol embolization; renal insufficiency; skin necrosis; ulcer

Year:  2009        PMID: 21886725      PMCID: PMC3157794          DOI: 10.3315/jdcr.2009.1031

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  11 in total

Review 1.  Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature.

Authors:  Kaoru Funabiki; Hiroshi Masuoka; Hiroyuki Shimizu; Yoshiharu Emi; Takuya Mori; Masaaki Ito; Takeshi Nakano
Journal:  Jpn Heart J       Date:  2003-09

Review 2.  Cholesterol embolization syndrome induced by thrombolytic therapy.

Authors:  Wassim A Hitti; Ravinder K Wali; Edward J Weinman; Edward J Weiman; Cinthia Drachenberg; Andrew Briglia
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

3.  Cutaneous cholesterol embolization.

Authors:  Joshua E Lane; Tanda N Lane; Marissa Shams; Carl E Lane
Journal:  J Am Acad Dermatol       Date:  2009-04       Impact factor: 11.527

Review 4.  Cholesterol crystal embolization: a review of 221 cases in the English literature.

Authors:  M J Fine; W Kapoor; V Falanga
Journal:  Angiology       Date:  1987-10       Impact factor: 3.619

Review 5.  Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors.

Authors:  M Pennington; J Yeager; H Skelton; K J Smith
Journal:  Br J Dermatol       Date:  2002-03       Impact factor: 9.302

6.  The cutaneous manifestations of cholesterol crystal embolization.

Authors:  V Falanga; M J Fine; W N Kapoor
Journal:  Arch Dermatol       Date:  1986-10

7.  Cholesterol emboli syndrome in type 2 diabetes: the disease history of a case evaluated with renal scintigraphy.

Authors:  Giorgina B Piccoli; Antonella Sargiotto; Manuel Burdese; Loredana Colla; Donatella Bilucaglia; Andrea Magnano; Valentina Consiglio; Giuseppe Piccoli; Giuseppe Picciotto
Journal:  Rev Diabet Stud       Date:  2005-08-10

8.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.

Authors:  Yoshihiro Fukumoto; Hiroyuki Tsutsui; Miyuki Tsuchihashi; Akihiro Masumoto; Akira Takeshita
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

9.  Cholesterol embolism to the skin.

Authors:  L Borrego; R Gil; A Mazuecos; R Ruiz; J L López; L Iglesias
Journal:  Clin Exp Dermatol       Date:  1992-11       Impact factor: 3.470

10.  Subacute renal failure in diabetic nephropathy due to endocapillary glomerulonephritis and cholesterol embolization.

Authors:  F Rivera; C Vazmediano; L Gonzalez-Lopez; A Carrano; J Blanco
Journal:  J Nephrol       Date:  2008 Jul-Aug       Impact factor: 3.902

View more
  2 in total

1.  Atherosclerosis associated with vasculopathic lesions in a golden retriever with hypercholesterolemia.

Authors:  Nicole A Boynosky; Laura Stokking
Journal:  Can Vet J       Date:  2014-05       Impact factor: 1.008

Review 2.  Pigmented purpura and cutaneous vascular occlusion syndromes.

Authors:  Ana Cecilia Lamadrid-Zertuche; Verónica Garza-Rodríguez; Jorge de Jesús Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.